Home
Henlius

Henlius Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domainhenlius.com

Year Founded2010

Employees51 - 200

Annual Revenue> $1B

Henlius

Henlius (including company regionals)

henlius.com

See more website traffic and engagement information

Henlius Revenue up to June 2026 is > 1B

revenue generated by Henlius top domains

Henlius top domains revenue over 3 years

Revenue for Henlius top domains

henlius.com> 1B

See more with Sales Intelligence

Total visits to Henlius's top domains

Understand Henlius market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

henlius.com20.5K

See more with Sales Intelligence

Avg. visit duration in Henlius's top domains

Analyze Henlius engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

henlius.com00:00:21

See more with Sales Intelligence

Avg. pageviews on Henlius's top domains

See how Henlius keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

henlius.com1.56

See more with Sales Intelligence

Henlius top competitors by domain

Top similar sites in June 2026, ranked by their affinity

cytokinetics.comCompany NameCytokineticsEmployees201 - 500HQUnited States, California, South San FranciscoAnnual revenue$50M - $75MTotal visits104.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Henlius

These are the website technologies, by industry, used by Henlius top domains

Content Management System (2)

WordPress

Conversion & Analytics (2)

Clarity

Advertising (1)

PubMatic

Email Services (1)

Microsoft Exchange Online

More Technologies

2

See all

News & Signals from Henlius

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHenlius Biotech Co. Ltd. attended event American Association for Cancer Research (AACR) Annual Meeting 2026 on Apr 23rd '26.LUND, SE / ACCESS Newswire / April 23, 2026 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today announced that Shanghai Henlius Biotech, Inc. has presented preclinical data for HLX49, a HER2 biparatopic antibody-drug conjugate (ADC), at the American Association for Cancer Research (AACR) Annual Meeting 2026, held in San Diego, USA, from 17-22 April 2026.

NewsHenlius Biotech Co. Ltd. is developing serplulimab in Europe on Jul 1st '23.In a separate 2023 agreement Henlius granted Intas Pharmaceuticals exclusive rights to develop and commercialize serplulimab in Europe and India, while Fosun Pharma is responsible for serplulimab in the US.

NewsHenlius Biotech Co. Ltd. attended event 2026 J.P. Morgan Healthcare Conference on Jan 1st '26.As mentioned in Dr. Zhu's presentation at this year's J.P. Morgan conference, Henlius is building a diverse and integrated product pipeline centered on oncology with expected expansions into autoimmune and inflammatory diseases.